Saturday, June 01, 2024 12:56:22 AM
MOC Market On Close Orders. 2.3MILLION shares
31 May 2024 As of 16:00 EDT we had 699,000 shares traded by the close at a final price of $4.09. The MOC orders were processed at 4:00PM a total of 2.3Million shares at $4.09 .... later a few more buys were made in afterhours 40K with last price of $4.14
Explanations below as to what is an MOC order is and perhaps some explanations as to why someone would use such an order. I copied them from a couple different brokers.
Market-on-Close (MOC) Orders Info:
A Market-on-Close (MOC) order is a market order that is submitted to execute as close to the closing price as possible.
Summary of NYSE markets (NYSE, NYSE MKT, NYSE Arca) rules for entering/canceling/modifying market-on-close (MOC)
All MOC orders must be received at NYSE markets by 15:50 ET, unless entered to offset a published imbalance.
NYSE markets' rules also prohibit the cancellation or reduction in size of any market-on-close (MOC) order after 15:45 ET.
Summary of Nasdaq rules for entering/canceling/modifying market-on-close (MOC)
All MOC orders must be received at Island by 15:55:00 EST, but may not be canceled or modified after 15:50 EST.
Key Takeaways
A market-on-close (MOC) order is a non-limit market order that is executed at or after the closing of a stock exchange.
Traders generally would place a MOC order in anticipation of a stock's movement the next day.
A surge of MOC orders can create trade imbalances at the end of the trading day.
Many days you see MOC orders at the end of normal trade day. For Anavex most times they are 50K to 100K total orders. Thursday it was a bit more than "Normal" We ended normal trade day Thursday with 539K and the MOC orders were something around 306K shares for a total of 845K. That was considerably about our "Normal". MOST DAYS I see MOC orders of 50k to 70k. Not enough to make anyone wonder Whats Up? Friday was one hellava difference. We went from 699K to 3Million traded shares. So 2.3Million shares traded as MOC Market On Close shares. Undoubtedly this created an Imbalance. So maybe MONDAY might be an interesting day?? I guess maybe we will find out on Monday Morning? This could be any number of things that caused this to happen.
Enjoy your weekend
John k9uwa
31 May 2024 As of 16:00 EDT we had 699,000 shares traded by the close at a final price of $4.09. The MOC orders were processed at 4:00PM a total of 2.3Million shares at $4.09 .... later a few more buys were made in afterhours 40K with last price of $4.14
Explanations below as to what is an MOC order is and perhaps some explanations as to why someone would use such an order. I copied them from a couple different brokers.
Market-on-Close (MOC) Orders Info:
A Market-on-Close (MOC) order is a market order that is submitted to execute as close to the closing price as possible.
Summary of NYSE markets (NYSE, NYSE MKT, NYSE Arca) rules for entering/canceling/modifying market-on-close (MOC)
All MOC orders must be received at NYSE markets by 15:50 ET, unless entered to offset a published imbalance.
NYSE markets' rules also prohibit the cancellation or reduction in size of any market-on-close (MOC) order after 15:45 ET.
Summary of Nasdaq rules for entering/canceling/modifying market-on-close (MOC)
All MOC orders must be received at Island by 15:55:00 EST, but may not be canceled or modified after 15:50 EST.
Key Takeaways
A market-on-close (MOC) order is a non-limit market order that is executed at or after the closing of a stock exchange.
Traders generally would place a MOC order in anticipation of a stock's movement the next day.
A surge of MOC orders can create trade imbalances at the end of the trading day.
Many days you see MOC orders at the end of normal trade day. For Anavex most times they are 50K to 100K total orders. Thursday it was a bit more than "Normal" We ended normal trade day Thursday with 539K and the MOC orders were something around 306K shares for a total of 845K. That was considerably about our "Normal". MOST DAYS I see MOC orders of 50k to 70k. Not enough to make anyone wonder Whats Up? Friday was one hellava difference. We went from 699K to 3Million traded shares. So 2.3Million shares traded as MOC Market On Close shares. Undoubtedly this created an Imbalance. So maybe MONDAY might be an interesting day?? I guess maybe we will find out on Monday Morning? This could be any number of things that caused this to happen.
Enjoy your weekend
John k9uwa
Bullish
Recent AVXL News
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
- Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/09/2026 12:30:00 PM
- Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026 • GlobeNewswire Inc. • 02/03/2026 12:30:00 PM
- Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease • GlobeNewswire Inc. • 01/13/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 10:26:26 PM
- Edelson Lechtzin LLP Announces an Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Investors with Substantial Losses Contact the Firm • PR Newswire (US) • 01/09/2026 01:13:00 AM
- Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology • GlobeNewswire Inc. • 01/08/2026 12:30:00 PM
- Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program • GlobeNewswire Inc. • 01/06/2026 12:30:00 PM
- Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion • GlobeNewswire Inc. • 12/18/2025 12:30:00 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 12/12/2025 09:05:00 PM
